Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
Marie LagougeInstitut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS / INSERM / ULP, 67404 Illkirch, FranceCarmen ArgmannInstitut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS / INSERM / ULP, 67404 Illkirch, FranceZachary Gerhart‐HinesDepartment of Cell Biology, John Hopkins University School of Medicine, Baltimore, MD 21205, USAHamid MézianeInstitut Clinique de la Souris, BP10142, 67404, Illkirch, FranceCarles LerínDepartment of Cell Biology, John Hopkins University School of Medicine, Baltimore, MD 21205, USAFrédéric DaussinDepartment of Respiratory, Cardiocirculatory and Exercise Physiology, Hôpitaux Universitaires, 67000 Strasbourg, FranceNadia MessadeqInstitut Clinique de la Souris, BP10142, 67404, Illkirch, FranceJill C. MilneSirtris Pharmaceutical, Cambridge, MA 02139, USAPhilip LambertSirtris Pharmaceutical, Cambridge, MA 02139, USAPeter J. ElliottSirtris Pharmaceutical, Cambridge, MA 02139, USABernard GényDepartment of Respiratory, Cardiocirculatory and Exercise Physiology, Hôpitaux Universitaires, 67000 Strasbourg, FranceMarkku LaaksoDepartment of Medicine, University of Kuopio, 70211 Kuopio, FinlandPere PuigserverDepartment of Cell Biology, John Hopkins University School of Medicine, Baltimore, MD 21205, USAJohan AuwerxIGBMC-ICS, 67404 Illkirch, France
2006en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0